Schedule 13G ownership disclosure

Ultragenyx Pharmaceutical Inc

Security class unavailable · CUSIP: 90400D108

Event date: 2023-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,415,029
Percent of class
5.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-24-000136
Form type
SC 13G/A
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
Feb 08, 2024
Reporting period
Dec 29, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub